Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness league tables: valuable guidance for decision makers?

Josephine Mauskopf1, Frans Rutten, Warren Schonfeld

  • 1Health Economics and Outcomes Strategy, RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA. jmauskopf@rti.org

Pharmacoeconomics
|September 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incorporating angina into the H<sub>2</sub>FPEF score improves diagnostic performance for HFpEF in women.

Open heart·2026
Same author

The plasma proteome is linked to echocardiographic parameters and stages of diastolic dysfunction, across the ejection fraction spectrum.

International journal of cardiology·2025
Same author

Sex differences in the prescription of antihypertensive medications in primary care patients: an observational study.

BJGP open·2025
Same author

Longitudinal cardiac imaging for assessment of myocardial injury in non-hospitalised community-dwelling individuals after COVID-19 infection: the Rotterdam Study.

Heart (British Cardiac Society)·2025
Same author

Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States.

Vaccines·2024
Same author

Systematic Literature Review of Risk Factors for Poor Outcomes Among Adults With Respiratory Syncytial Virus Infection in High-Income Countries.

Open forum infectious diseases·2023
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
Same journal

Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

PharmacoEconomics·2026
Same journal

Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

PharmacoEconomics·2026
See all related articles

Cost-effectiveness league tables can be improved for healthcare decision-making. This study proposes a reference case approach and expanded measures for more consistent and effective use of incremental cost-effectiveness ratios (ICERs).

Area of Science:

  • Health Economics
  • Health Technology Assessment
  • Decision Science

Background:

  • Cost-effectiveness league tables rank healthcare interventions using incremental cost-effectiveness ratios (ICERs).
  • These tables are valuable for resource allocation but often use inconsistent methodologies.
  • Methodological variations can impact intervention rankings and decision-making.

Purpose of the Study:

  • To evaluate the utility of cost-effectiveness league tables for decision-makers.
  • To address limitations in current league table methodologies and data presentation.
  • To propose improvements for more reliable and consistent healthcare intervention evaluation.

Main Methods:

  • Critically reviewed existing methodologies for computing incremental cost-effectiveness ratios (ICERs).

Related Experiment Videos

  • Proposed a standardized 'reference case' approach for ICER calculation.
  • Recommended an expanded set of measures for inclusion in league tables.

    • Main Results:

    • Identified significant methodological heterogeneity in current ICER calculations (e.g., comparators, discount rates, time horizons).
    • Highlighted the general absence of uncertainty measures in existing league tables.
    • Proposed a framework for a central repository of standardized league tables.

    Conclusions:

    • Current cost-effectiveness league tables present challenges for consistent decision-making due to methodological variations.
    • A reference case approach and expanded measures can enhance the reliability and comparability of ICERs.
    • Standardized league tables in a central repository would improve their utility for healthcare resource allocation.